Drug Profile
Research programme: ghrelin receptor agonist - Helsinn
Alternative Names: HM 03; HM03 ghrelin receptor agonist 2Latest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator Helsinn
- Class
- Mechanism of Action Ghrelin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anorexia; Cachexia
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Anorexia in Europe (unspecified route)
- 29 Aug 2023 Discontinued - Preclinical for Cachexia in Europe (unspecified route)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Anorexia in Europe